OTC or DOA? –

January 18, 2019 –  The FDA has developed a model Drug Facts Label (DFL) with “easy-to-understand pictograms on how to use the drug” … “FDA’s development work here is extraordinary, and reflects their longstanding desire to see a pharmaceutical company take naloxone OTC  (over-the-counter),” says Amy Arthur, director of public and government relations at Harm Reduction Therapeutics, a non-profit trying to develop an over-the-counter naloxone product … with the FDA leading development and comprehension testing of the Naloxone DFL, “Responsibility now falls squarely on the shoulders of industry,”…

Full Story @ FilterMag.org


Subscribe Today! Your best source of current news, information and opinion about the issues that matter to you most. Serving the treatment industry, recovery community and health and wellness professionals.